Jemma Arakelyan: An incredible ESMO Advanced Course on EGFR in Lung Cancer

Jemma Arakelyan, CEO of the Institute of Cancer and Crisis, shared on LinkedIn:

“Thank you, European Society of Medical Oncology, for an incredible ESMO Advanced Course on EGFR in Lung Cancer, uniting people worldwide!
Grateful for the opportunity to learn and connect.”

Source: Jemma Arakelyan / LinkedIn

Jemma Arakelyan, MD is the CEO of the Institute of Cancer and Crisis (ICC), an Adjunct Assistant Professor at the Department of Hematology and Pediatric Oncology of the Yerevan State Medical University (YSMU), Adviser and Medical Oncologist at the Immune Oncology Research Institute (IMMONC) and a PhD program candidate at the Department of Chemistry of the City University of Hong Kong. She is an Editorial Board Member of OncoDaily.